• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Patterns in drug utilization--national and international aspects: antihypertensive drugs.

作者信息

Baksaas I

出版信息

Acta Med Scand Suppl. 1984;683:59-66. doi: 10.1111/j.0954-6820.1984.tb08717.x.

DOI:10.1111/j.0954-6820.1984.tb08717.x
PMID:6146249
Abstract

There is a reasonable agreement between defined daily doses (DDDs) and prescribed daily doses (PDDs) of antihypertensive drugs, at least in Norway and Sweden. Sales and prescriptions of antihypertensive drugs in seven European countries (CSSR, Denmark, Finland, Iceland, Northern Ireland, Norway and Sweden) have increased 50 to 200% during the last 10 years. The drug statistics also illustrate marked qualitative and quantitative differences in the utilization of antihypertensive drugs between these seven European countries. Mortality in cardiovascular diseases also differs between these countries, particularly between Northern Ireland and Finland and the other countries. So do sales of alcohol and tobacco. However, none of these factors seem to co-vary with drug utilization.

摘要

相似文献

1
Patterns in drug utilization--national and international aspects: antihypertensive drugs.
Acta Med Scand Suppl. 1984;683:59-66. doi: 10.1111/j.0954-6820.1984.tb08717.x.
2
Nonaspirin Nonsteroidal Antiinflammatory Drug Use in the Nordic Countries from a Cardiovascular Risk Perspective, 2000-2016: A Drug Utilization Study.从心血管风险角度看 2000-2016 年北欧国家的非阿司匹林类非甾体抗炎药使用情况:一项药物利用研究。
Pharmacotherapy. 2019 Feb;39(2):150-160. doi: 10.1002/phar.2217. Epub 2019 Feb 8.
3
Validation of observed differences in the utilization of antihypertensive and antidiabetic drugs in Northern Ireland, Norway and Sweden.对北爱尔兰、挪威和瑞典抗高血压药与抗糖尿病药使用情况观察到的差异进行验证。
Eur J Clin Pharmacol. 1985;29(1):1-8. doi: 10.1007/BF00547360.
4
Therapeutic traditions in Northern Ireland, Norway and Sweden: II. Hypertension. WHO Drug Utilization Research Group (DURG).
Eur J Clin Pharmacol. 1986;30(5):521-5. doi: 10.1007/BF00542409.
5
Between-country variation in the utilization of antihypertensive agents: Guidelines and clinical practice.各国在抗高血压药物使用方面的差异:指南与临床实践
J Hum Hypertens. 2006 Dec;20(12):917-22. doi: 10.1038/sj.jhh.1002089. Epub 2006 Sep 21.
6
Patterns in drug utilization--national and international aspects: psychoactive drugs 1966-80.
Acta Med Scand Suppl. 1984;683:71-7. doi: 10.1111/j.0954-6820.1984.tb08719.x.
7
Consumption of analgesics and anti-inflammatory drugs in the nordic countries between 1978-1988.1978年至1988年间北欧国家镇痛药和抗炎药的消费情况。
Eur J Clin Pharmacol. 1991;41(1):37-42. doi: 10.1007/BF00280103.
8
A community pharmacy-based survey of antihypertensive and antidiabetic drug dosages in Northern Ireland.
J Clin Hosp Pharm. 1983 Jun;8(2):115-24. doi: 10.1111/j.1365-2710.1983.tb01040.x.
9
Patterns of finasteride use in the male populations of four Nordic countries: A cross-national drug utilization study.四个北欧国家男性人群中非那雄胺的使用模式:一项跨国药物利用研究。
Scand J Urol. 2016 Jun;50(3):220-7. doi: 10.3109/21681805.2015.1136676. Epub 2016 Feb 22.
10
Trends in Use of Paracetamol in the Nordic Countries.北欧国家扑热息痛使用趋势。
Basic Clin Pharmacol Toxicol. 2018 Sep;123(3):301-307. doi: 10.1111/bcpt.13003. Epub 2018 Apr 20.

引用本文的文献

1
Drug utilisation studies as tools in health economics.药物利用研究作为卫生经济学中的工具。
Pharmacoeconomics. 1994 Apr;5(4):299-312. doi: 10.2165/00019053-199405040-00005.
2
Economic factors in the initiation of antihypertensive therapy.启动抗高血压治疗的经济因素。
Pharmacoeconomics. 1992 Oct;2(4):324-34. doi: 10.2165/00019053-199202040-00007.
3
Impact of drug usage review on drug utilisation.药物使用审查对药物利用的影响。
Pharmacoeconomics. 1993 Jan;3(1):14-21. doi: 10.2165/00019053-199303010-00003.
4
Drug utilization in paediatrics: non-medical factors affecting decision making by prescribers.儿科用药:影响开处方者决策的非医学因素。
Eur J Clin Pharmacol. 1984;27(2):237-41. doi: 10.1007/BF00544052.
5
Validation of observed differences in the utilization of antihypertensive and antidiabetic drugs in Northern Ireland, Norway and Sweden.对北爱尔兰、挪威和瑞典抗高血压药与抗糖尿病药使用情况观察到的差异进行验证。
Eur J Clin Pharmacol. 1985;29(1):1-8. doi: 10.1007/BF00547360.
6
Therapeutic traditions in Northern Ireland, Norway and Sweden: II. Hypertension. WHO Drug Utilization Research Group (DURG).
Eur J Clin Pharmacol. 1986;30(5):521-5. doi: 10.1007/BF00542409.
7
Therapeutic auditing at the national and international level.国家和国际层面的治疗性审计。
Br J Clin Pharmacol. 1986;22 Suppl 1(Suppl 1):55S-59S. doi: 10.1111/j.1365-2125.1986.tb02983.x.
8
Therapeutic traditions in Northern Ireland, Norway and Sweden: I. Diabetes. WHO Drug Utilization Research Group (DURG).
Eur J Clin Pharmacol. 1986;30(5):513-9. doi: 10.1007/BF00542408.
9
Utilization of benzodiazepines in Chile during 1982-1986.1982年至1986年期间智利苯二氮䓬类药物的使用情况。
Eur J Clin Pharmacol. 1989;37(2):139-43. doi: 10.1007/BF00558221.
10
Changing patterns of antihypertensive drug use in a German population between 1984 and 1987. Results of a population based cohort study in the Federal Republic of Germany.1984年至1987年间德国人群中抗高血压药物使用模式的变化。德意志联邦共和国一项基于人群的队列研究结果。
Eur J Clin Pharmacol. 1990;39(1):1-7. doi: 10.1007/BF02657047.